Roberto P. Rosenkranz

467 total citations
25 papers, 372 citations indexed

About

Roberto P. Rosenkranz is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Roberto P. Rosenkranz has authored 25 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Roberto P. Rosenkranz's work include Chemical Synthesis and Analysis (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Synthesis of heterocyclic compounds (3 papers). Roberto P. Rosenkranz is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Synthesis of heterocyclic compounds (3 papers). Roberto P. Rosenkranz collaborates with scholars based in United States, Poland and Czechia. Roberto P. Rosenkranz's co-authors include Kenneth L. Melmon, Ross E. Rocklin, Keith F. Killam, Michael S. Verlander, Kenneth A. Jacobson, Murray Goodman, Markus Nießen, Heinz‐Josef Hirsch, Fritz Kreuzaler and Christoph Peterhänsel and has published in prestigious journals such as The American Journal of Medicine, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Roberto P. Rosenkranz

25 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto P. Rosenkranz United States 12 188 74 70 51 46 25 372
Richard G. Conway United States 11 223 1.2× 82 1.1× 74 1.1× 24 0.5× 71 1.5× 24 458
Takashi Nose Japan 12 198 1.1× 101 1.4× 62 0.9× 69 1.4× 19 0.4× 59 514
Toshikatsu Nakabayashi Japan 13 281 1.5× 30 0.4× 19 0.3× 46 0.9× 28 0.6× 37 461
SHIGERU AONUMA Japan 12 223 1.2× 26 0.4× 50 0.7× 32 0.6× 41 0.9× 76 466
Motonori Aoki Japan 11 152 0.8× 48 0.6× 72 1.0× 59 1.2× 94 2.0× 18 343
Beverly A. Simko United States 9 146 0.8× 104 1.4× 58 0.8× 36 0.7× 23 0.5× 16 348
Motoyuki Moriga Japan 12 173 0.9× 133 1.8× 45 0.6× 63 1.2× 10 0.2× 51 494
Earl F. Kimble Switzerland 10 79 0.4× 36 0.5× 105 1.5× 197 3.9× 58 1.3× 19 411
David P. Blakeman United States 15 342 1.8× 96 1.3× 56 0.8× 15 0.3× 12 0.3× 24 559
Butcher Rw United States 8 143 0.8× 60 0.8× 13 0.2× 66 1.3× 18 0.4× 15 327

Countries citing papers authored by Roberto P. Rosenkranz

Since Specialization
Citations

This map shows the geographic impact of Roberto P. Rosenkranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto P. Rosenkranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto P. Rosenkranz more than expected).

Fields of papers citing papers by Roberto P. Rosenkranz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto P. Rosenkranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto P. Rosenkranz. The network helps show where Roberto P. Rosenkranz may publish in the future.

Co-authorship network of co-authors of Roberto P. Rosenkranz

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto P. Rosenkranz. A scholar is included among the top collaborators of Roberto P. Rosenkranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto P. Rosenkranz. Roberto P. Rosenkranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bocci, Maria Grazia, Riccardo Maviglia, Domenico Luca Grieco, et al.. (2020). Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.. PubMed. 24(23). 12466–12479. 23 indexed citations
2.
Nießen, Markus, Roberto P. Rosenkranz, Rashad Kebeish, et al.. (2007). Mitochondrial glycolate oxidation contributes to photorespiration in higher plants. Journal of Experimental Botany. 58(10). 2709–2715. 39 indexed citations
3.
4.
Sharif, Najam A., et al.. (1995). Chronic manipulation of dietary salt modulates renal physiology and kidney dopamine receptor subtypes: Functional and autoradiographic studies. General Pharmacology The Vascular System. 26(4). 727–735. 5 indexed citations
5.
Fisher, Lawrence E., Roberto P. Rosenkranz, Robin D. Clark, et al.. (1995). N,N-6-bis-[2-(3,4-dihydroxybenzyl)pyrrolidinyl]hexane, a potent, selective, orally active dopamine analog with hypotensive and diuretic activity. Bioorganic & Medicinal Chemistry Letters. 5(20). 2371–2376. 11 indexed citations
6.
Sharif, N.A., et al.. (1992). A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: Binding to dopamine transporters?. Neurochemistry International. 21(1). 69–73. 4 indexed citations
7.
Everett, Allen D., et al.. (1992). Renin and angiotensinogen expression during the evolution of diabetes.. Hypertension. 19(1). 70–78. 24 indexed citations
8.
Hirschfeld, Donald R., et al.. (1989). [(1H-Imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors. Journal of Medicinal Chemistry. 32(4). 890–897. 17 indexed citations
9.
Clark, Robin D., Joan M. Caroon, Nancy E. Isaac, et al.. (1987). Synthesis and Pharmacological Evaluation of N,N-di-n-Propyldopamine Congeners Containing Phenolic Bioisosteres. Journal of Pharmaceutical Sciences. 76(5). 411–415. 8 indexed citations
10.
Khan, Manzoor M., et al.. (1987). In vitro pharmacologic activity of congener derivatives and model conjugates of propranolol and practolol. Biochemical Pharmacology. 36(13). 2175–2182. 2 indexed citations
11.
Reitz, Allen B., Mitchell A. Avery, Roberto P. Rosenkranz, et al.. (1985). Conjugates of Catecholamines. 6. Synthesis and β-Adrenergic Activity of N - (Hydroxyalkyl)catecholamine Derivatives. Journal of Medicinal Chemistry. 28(5). 642–647. 6 indexed citations
12.
Verlander, Michael S., Kenneth A. Jacobson, Roberto P. Rosenkranz, Kenneth L. Melmon, & Murray Goodman. (1983). Some novel approaches to the design and synthesis of peptide–catecholamine conjugates. Biopolymers. 22(1). 531–545. 11 indexed citations
13.
Rosenkranz, Roberto P., Brian B. Hoffman, Kenneth A. Jacobson, et al.. (1983). Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol.. Molecular Pharmacology. 24(3). 429–435. 10 indexed citations
14.
Rosenkranz, Roberto P., et al.. (1983). Conjugates of catecholamines. IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates.. Journal of Pharmacology and Experimental Therapeutics. 227(2). 267–273. 15 indexed citations
15.
Jacobson, Kenneth A., et al.. (1983). Conjugates of catecholamines. 1. N-Alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol. Journal of Medicinal Chemistry. 26(4). 492–499. 30 indexed citations
16.
Melmon, Kenneth L., Ross E. Rocklin, & Roberto P. Rosenkranz. (1981). Autacoids as modulators of the inflammatory and immune response. The American Journal of Medicine. 71(1). 100–106. 68 indexed citations
17.
Rosenkranz, Roberto P. & Keith F. Killam. (1981). Anticonvulsant effects of PGE2 on electrical, chemical and photomyoclonic animal models of epilepsy. Progress in Lipid Research. 20. 515–522. 7 indexed citations
18.
Rosenkranz, Roberto P. & Keith F. Killam. (1979). Effects of intracerebroventricular administration of prostaglandins E1 and E2 on chemically induced convulsions in mice.. Journal of Pharmacology and Experimental Therapeutics. 209(2). 231–237. 24 indexed citations
19.
Rosenkranz, Roberto P. & Keith F. Killam. (1978). Effects of prostacyclin and 6-keto PGF1α on electrically induced convulsions in mice. Life Sciences. 23(26). 2609–2616. 7 indexed citations
20.
Rosenkranz, Roberto P.. (1978). Effects of intracerebroventricular administration of PGE1, E2 and F2α on electrically induced convulsions in mice. Prostaglandins. 15(6). 925–942. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard G. Conway Breakdown of academic impact, for papers by Takashi Nose Breakdown of academic impact, for papers by Toshikatsu Nakabayashi Breakdown of academic impact, for papers by SHIGERU AONUMA Breakdown of academic impact, for papers by Motonori Aoki Breakdown of academic impact, for papers by Beverly A. Simko Breakdown of academic impact, for papers by Motoyuki Moriga Breakdown of academic impact, for papers by Earl F. Kimble Breakdown of academic impact, for papers by David P. Blakeman Breakdown of academic impact, for papers by Butcher Rw
Rankless by CCL
2026